Global Blood Group Typing Market 2023-2029

March 2023 | 67 pages | ID: G622A90A6B1EEN
Gen Consulting Company

Abstracts

Blood group typing is typically performed using a small blood sample, which is then sent to a laboratory for testing. Results are usually available on the same day or the next day, depending on the laboratory's policies. Blood group typing is a simple and essential test that enables healthcare professionals to provide safe and effective medical care to patients. The global blood group typing market is expected to increase by USD 2.9 billion, at a compound annual growth rate (CAGR) of 10.25% from 2023 to 2029, according to the latest edition of the Global Blood Group Typing Market Report.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global blood group typing market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the technology, test type, products type, end user, and region. The global market for blood group typing can be segmented by technology: PCR-based and microarray technique, massively parallel sequencing, assay-based techniques, others. The PCR-based and microarray technique segment was the largest contributor to the global blood group typing market in 2022. Blood group typing market is further segmented by test type: human leukocyte antigen (HLA) typing, antibody screening, ABO blood tests, cross-matching series, antigen typing. According to the research, the antibody screening segment had the largest share in the global blood group typing market. Based on products type, the blood group typing market is segmented into: instruments, services, consumables. The consumables segment held the largest revenue share in 2022. On the basis of end user, the blood group typing market also can be divided into: clinical laboratories, blood banks, hospitals, others. Globally, the blood banks segment made up the largest share of the blood group typing market. Blood group typing market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

Market Segmentation
By technology: PCR-based and microarray technique, massively parallel sequencing, assay-based techniques, others
By test type: human leukocyte antigen (HLA) typing, antibody screening, ABO blood tests, cross-matching series, antigen typing
By products type: instruments, services, consumables
By end user: clinical laboratories, blood banks, hospitals, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides analysis of the key companies of the industry and their detailed company profiles including Quotient Limited, Merck KGaA, The Novacyt Group, Agena Bioscience Inc., Grifols S.A., BAG Diagnostics GmbH, Immucor, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
To analyze and forecast the market size of the global blood group typing market.
To classify and forecast the global blood group typing market based on technology, test type, products type, end user, region.
To identify drivers and challenges for the global blood group typing market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global blood group typing market.
To identify and analyze the profile of leading players operating in the global blood group typing market.

Why Choose This Report
Gain a reliable outlook of the global blood group typing market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints

PART 5. MARKET BREAKDOWN BY TECHNOLOGY

PCR-based and microarray technique
Massively parallel sequencing
Assay-based techniques
Others

PART 6. MARKET BREAKDOWN BY TEST TYPE

Human leukocyte antigen (HLA) typing
Antibody screening
ABO blood tests
Cross-matching series
Antigen typing

PART 7. MARKET BREAKDOWN BY PRODUCTS TYPE

Instruments
Services
Consumables

PART 8. MARKET BREAKDOWN BY END USER

Clinical laboratories
Blood banks
Hospitals
Others

PART 9. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 10. KEY COMPANIES

Quotient Limited
Merck KGaA
The Novacyt Group
Agena Bioscience Inc.
Grifols S.A.
BAG Diagnostics GmbH
Immucor, Inc.

DISCLAIMER